JP Morgan Chase’s Bionano Genomics BNGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$12 Hold
11
﹤0.01% 7424
2025
Q4
$17 Hold
11
﹤0.01% 7313
2025
Q3
$19 Sell
11
-1
-8% -$3 ﹤0.01% 7286
2025
Q2
$39 Buy
12
+1
+9% +$4 ﹤0.01% 6911
2025
Q1
$31 Sell
11
-2
-15% -$13 ﹤0.01% 7057
2024
Q4
$222 Hold
13
﹤0.01% 6901
2024
Q3
$350 Sell
13
-51
-80% -$1.59K ﹤0.01% 6837
2024
Q2
$2.6K Buy
64
+51
+392% +$2.8K ﹤0.01% 6490
2024
Q1
$855 Sell
13
-73
-85% -$5.45K ﹤0.01% 6661
2023
Q4
$9.8K Sell
86
-48
-36% -$5.01K ﹤0.01% 6408
2023
Q3
$24.3K Buy
134
+121
+931% +$31.7K ﹤0.01% 6020
2023
Q2
$4.7K Sell
13
-384
-97% -$173K ﹤0.01% 6182
2023
Q1
$265K Buy
397
+103
+35% +$91.5K ﹤0.01% 4888
2022
Q4
$257K Buy
294
+26
+10% +$32.7K ﹤0.01% 4909
2022
Q3
$294K Buy
268
+6
+2% +$7.93K ﹤0.01% 4767
2022
Q2
$217K Sell
262
-104
-28% -$107K ﹤0.01% 5034
2022
Q1
$567K Buy
366
+59
+19% +$79.6K ﹤0.01% 4626
2021
Q4
$551K Buy
307
+24
+8% +$64.2K ﹤0.01% 4767
2021
Q3
$935K Sell
283
-6
-2% -$21K ﹤0.01% 4360
2021
Q2
$1.27M Buy
+289
New +$1.14M ﹤0.01% 4126
2021
Q1
Sell
-7
Closed -$13K 6070
2020
Q4
$13K Sell
7
-105
-94% -$39.2K ﹤0.01% 5358
2020
Q3
$40K Buy
+112
New +$43.4K ﹤0.01% 5001

Other funds holding BNGO

JP Morgan Chase's BNGO Position: Q1 2026 in Review

JP Morgan Chase held its Bionano Genomics (BNGO) position steady in Q1 2026 at 11 shares worth $12. The position accounts for ﹤0.01% of the portfolio, ranked #7424.

JP Morgan Chase first reported a position in BNGO in Q3 2020 and has held it in 22 quarters since. The position peaked at $1.27M in Q2 2021. 32 funds tracked by Wall St. Rank hold BNGO as of Q1 2026.

  • JP Morgan Chase held 11 shares of Bionano Genomics worth $12 as of Q1 2026.
  • JP Morgan Chase left its Bionano Genomics share count unchanged in Q1 2026.
  • Bionano Genomics made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #7424 holding.
  • JP Morgan Chase first reported a position in Bionano Genomics in Q3 2020 and has held it in 22 quarters since.
  • JP Morgan Chase's Bionano Genomics position peaked at $1.27M in Q2 2021.
  • 32 funds tracked by Wall St. Rank held Bionano Genomics as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.